Literature DB >> 2097342

Recurrent respiratory symptoms in the first year of life following preterm delivery.

A Greenough1, I Maconochie, B Yuksel.   

Abstract

Recurrent respiratory symptoms in the first year of life following preterm delivery were documented in two studies. In the first study a questionnaire was sent to all parents of preterm very low birth weight (VLBW) infants who had been admitted during a six-month period to the Neonatal Intensive Care Unit (NICU) at King's College Hospital (KCH) and who lived within the local district. Questionnaires were also sent to parents of a control group of infants who were recruited by random selection. All the controls lived locally and were delivered at KCH in the same six-month period as the study group, but were born at 37-41 weeks of gestation and had had no neonatal problems. The questionnaire documented frequency of cough and wheeze, medication and hospital admissions. Recurrent respiratory symptoms (wheeze or wheeze and cough) occurred in 65% of the preterm VLBW infants but only 33% of the controls p less than 0.001. Less than 10% of infants in either group had received bronchodilator therapy. Admission to hospital in both groups was more common amongst children who had recurrent wheeze (p less than 0.01). In the second study all preterm VLBW infants admitted to the NICU in a six-month period were followed prospectively over the first year of life. The nature and frequency of respiratory symptoms and frequency and length of re-admission was documented and related to the duration of neonatal ventilation. Twenty-three of the 44 preterm VLBW infants (53%) followed prospectively had recurrent wheeze and/or cough.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2097342     DOI: 10.1515/jpme.1990.18.6.489

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  16 in total

1.  Diagnosing and treating chesty infants. A short trial of inhaled corticosteroid is probably the best approach.

Authors:  D Cochran
Journal:  BMJ       Date:  1998-05-23

2.  Recurrent wheezing in very preterm infants.

Authors:  D E Elder; R Hagan; S F Evans; H R Benninger; N P French
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

3.  Bronchiolitis and asthma: are they related?

Authors:  L I Landau
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

4.  Effects of prematurity and intrauterine growth on respiratory health and lung function in childhood.

Authors:  R J Rona; M C Gulliford; S Chinn
Journal:  BMJ       Date:  1993-03-27

Review 5.  Is there a link between wheezing in early childhood and adverse birth outcomes? A systematic review.

Authors:  Evridiki Patelarou; Maria Chochlidaki; Victoria Vivilaki; Hero Brokalaki
Journal:  Int J Environ Res Public Health       Date:  2009-11-03       Impact factor: 3.390

6.  The effect of sodium cromoglycate on upper and lower respiratory symptoms in children born prematurely.

Authors:  B Yuksel; A Greenough
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

7.  One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial.

Authors:  Anna Maria Hibbs; Michele C Walsh; Richard J Martin; William E Truog; Scott A Lorch; Evaline Alessandrini; Avital Cnaan; Lisa Palermo; Sandra R Wadlinger; Christine E Coburn; Philip L Ballard; Roberta A Ballard
Journal:  J Pediatr       Date:  2008-06-04       Impact factor: 4.406

8.  Does the duration of oxygen dependence after birth influence subsequent respiratory morbidity?

Authors:  F Giffin; A Greenough; B Yuksel
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

9.  Acute deteriorations in neonatal chronic lung disease.

Authors:  B Yuksel; A Greenough
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

10.  Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up.

Authors:  B Yuksel; A Greenough
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.